295 related articles for article (PubMed ID: 30360725)
1. Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization.
Mortezaee K; Shabeeb D; Musa AE; Najafi M; Farhood B
Curr Clin Pharmacol; 2019; 14(1):41-53. PubMed ID: 30360725
[TBL] [Abstract][Full Text] [Related]
2. Radiation Protection and Mitigation by Natural Antioxidants and Flavonoids: Implications to Radiotherapy and Radiation Disasters.
Yahyapour R; Shabeeb D; Cheki M; Musa AE; Farhood B; Rezaeyan A; Amini P; Fallah H; Najafi M
Curr Mol Pharmacol; 2018; 11(4):285-304. PubMed ID: 29921213
[TBL] [Abstract][Full Text] [Related]
3. Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.
Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Salehi E; Nashtaei MS; Mirtavoos-Mahyari H; Motevaseli E; Shabeeb D; Musa AE; Najafi M
Clin Transl Oncol; 2019 Mar; 21(3):268-279. PubMed ID: 30136132
[TBL] [Abstract][Full Text] [Related]
4. Selenium as an adjuvant for modification of radiation response.
Farhood B; Mortezaee K; Motevaseli E; Mirtavoos-Mahyari H; Shabeeb D; Eleojo Musa A; Sanikhani NS; Najafi M; Ahmadi A
J Cell Biochem; 2019 Nov; 120(11):18559-18571. PubMed ID: 31190419
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms for Radioprotection by Melatonin; Can it be Used as a Radiation Countermeasure?
Amini P; Mirtavoos-Mahyari H; Motevaseli E; Shabeeb D; Musa AE; Cheki M; Farhood B; Yahyapour R; Shirazi A; Goushbolagh NA; Najafi M
Curr Mol Pharmacol; 2019; 12(1):2-11. PubMed ID: 30073934
[TBL] [Abstract][Full Text] [Related]
6. Protective Effect of Metformin, Resveratrol and Alpha-lipoic Acid on Radiation- Induced Pneumonitis and Fibrosis: A Histopathological Study.
Yahyapour R; Amini P; Saffar H; Motevaseli E; Farhood B; Pooladvand V; Shabeeb D; Musa AE; Najafi M
Curr Drug Res Rev; 2019; 11(2):111-117. PubMed ID: 31875783
[TBL] [Abstract][Full Text] [Related]
7. Protection from Radiation-induced Damage in Rat's Ileum and Colon by Combined Regimens of Melatonin and Metformin: A Histopathological Study.
Najafi M; Cheki M; Hassanzadeh G; Amini P; Shabeeb D; Musa AE
Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):180-189. PubMed ID: 31438832
[TBL] [Abstract][Full Text] [Related]
8. Appraisal of mechanisms of radioprotection and therapeutic approaches of radiation countermeasures.
Mishra KN; Moftah BA; Alsbeih GA
Biomed Pharmacother; 2018 Oct; 106():610-617. PubMed ID: 29990850
[TBL] [Abstract][Full Text] [Related]
9. Mitigation of Radiation-Induced Lung Pneumonitis and Fibrosis Using Metformin and Melatonin: A Histopathological Study.
Farhood B; Aliasgharzadeh A; Amini P; Rezaeyan A; Tavassoli A; Motevaseli E; Shabeeb D; Musa AE; Najafi M
Medicina (Kaunas); 2019 Jul; 55(8):. PubMed ID: 31366142
[No Abstract] [Full Text] [Related]
10. The role of amifostine as a radioprotector.
Wasserman TH; Brizel DM
Oncology (Williston Park); 2001 Oct; 15(10):1349-54; discussion 1357-60. PubMed ID: 11702962
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy and cell therapy for the management of radiation damages to healthy tissues: Rationale and early results.
Khalifa J; François S; Rancoule C; Riccobono D; Magné N; Drouet M; Chargari C
Cancer Radiother; 2019 Sep; 23(5):449-465. PubMed ID: 31400956
[TBL] [Abstract][Full Text] [Related]
12. NADPH Oxidase as a Target for Modulation of Radiation Response; Implications to Carcinogenesis and Radiotherapy.
Mortezaee K; Goradel NH; Amini P; Shabeeb D; Musa AE; Najafi M; Farhood B
Curr Mol Pharmacol; 2019; 12(1):50-60. PubMed ID: 30318012
[TBL] [Abstract][Full Text] [Related]
13. Review. Antioxidant gene therapeutic approaches to normal tissue radioprotection and tumor radiosensitization.
Greenberger JS; Epperly MW
In Vivo; 2007; 21(2):141-6. PubMed ID: 17436562
[TBL] [Abstract][Full Text] [Related]
14. Intercellular communications-redox interactions in radiation toxicity; potential targets for radiation mitigation.
Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Salehi E; Nashtaei MS; Shabeeb D; Musa AE; Fallah H; Najafi M
J Cell Commun Signal; 2019 Mar; 13(1):3-16. PubMed ID: 29911259
[TBL] [Abstract][Full Text] [Related]
15. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
Lee TK; Stupans I
J Pharm Pharmacol; 2002 Nov; 54(11):1435-45. PubMed ID: 12495545
[TBL] [Abstract][Full Text] [Related]
16. Targeting of cellular redox metabolism for mitigation of radiation injury.
Farhood B; Ashrafizadeh M; Khodamoradi E; Hoseini-Ghahfarokhi M; Afrashi S; Musa AE; Najafi M
Life Sci; 2020 Jun; 250():117570. PubMed ID: 32205088
[TBL] [Abstract][Full Text] [Related]
17. Current Status of Targeted Radioprotection and Radiation Injury Mitigation and Treatment Agents: A Critical Review of the Literature.
Kalman NS; Zhao SS; Anscher MS; Urdaneta AI
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):662-682. PubMed ID: 28581409
[TBL] [Abstract][Full Text] [Related]
18. Utilization of cytogenetic biomarkers as a tool for assessment of radiation injury and evaluation of radiomodulatory effects of various medicinal plants - a review.
Samarth RM; Samarth M; Matsumoto Y
Drug Des Devel Ther; 2015; 9():5355-72. PubMed ID: 26451089
[TBL] [Abstract][Full Text] [Related]
19. Radioprotective agents for radiation therapy: future trends.
Johnke RM; Sattler JA; Allison RR
Future Oncol; 2014 Dec; 10(15):2345-57. PubMed ID: 25525844
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?
Bourgier C; Levy A; Vozenin MC; Deutsch E
Cancer Metastasis Rev; 2012 Dec; 31(3-4):699-712. PubMed ID: 22706781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
